Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (mCRC) patients: a systematic literature review and meta-analysis

被引：0
|
作者：
Bylsma, Lauren C. [1 ]
Levin-Sparenberg, Elizabeth D. [2 ]
Lowe, Kimberly [3 ]
Sangare, Laura [4 ]
Fryzek, Jon [5 ]
Alexander, Dominik D. [2 ]
机构：
[1] EpidStrategies, Ann Arbor, MI USA
[2] EpidStat Inst, Ann Arbor, MI USA
[3] Amgen Inc, Seattle, WA USA
[4] SimulStat, Portland, OR USA
[5] EpidStrategies, Rockville, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
906
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [41] KRAS and NRAS mutations in metastatic Colorectal Cancer (CRCm) analyzed by pyrosequencing
    Carrera, R.
    Blazquez, C.
    Casalots, A.
    Posada, R.
    Ballester, R.
    Pozo, X.
    Vazquez, A.
    Ramos, M. C.
    Andreu, F. J.
    VIRCHOWS ARCHIV, 2015, 467 : S166 - S166
  • [42] The Coexistence of RAS and BRAF Mutations in Metastatic Colorectal Cancer: A Case Report and Systematic Literature Review
    Afrasanie, Vlad-Adrian
    Gafton, Bogdan
    Marinca, Mihai Vasile
    Alexa-Stratulat, Teodora
    Miron, Lucian
    Rusu, Cristina
    Ivanov, Anca-Viorica
    Balan, Gheorghe G.
    Croitoru, Adina-Emilia
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (02) : 253 - 258
  • [43] Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)
    Abid, Haisam
    Szabo, Aniko
    Taylor, Bradley W.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Kamgar, Mandana
    Thomas, James P.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [44] Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta-analysis
    Jia, Lu-Lu
    Zhao, Jian-Xin
    Zhao, Lian-Ping
    Tian, Jin-Hui
    Huang, Gang
    EUROPEAN JOURNAL OF RADIOLOGY, 2023, 158
  • [45] Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas
    Vakiani, E.
    Janackinaram, M.
    Shia, J.
    Saltz, L.
    Kemeny, N.
    Weiser, M.
    Solit, D.
    MODERN PATHOLOGY, 2011, 24 : 171A - 171A
  • [46] Mutation Analysis of KRAS NRAS and BRAF Genes Among Indian Patients with Colorectal Cancer
    Das, B.
    Bagadi, S.
    Nair, S.
    Chheda, P.
    Rau, S.
    Pany, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 905 - 905
  • [47] KRAS/NRAS/BRAF genotyping in patients with mestastatic colorectal cancer.
    Salas, Nuria Rodriguez
    Miranda, Jesus
    Ostios, Lorena
    Munoz, Mario
    Borobia, Alberto
    Gordo, Gema
    Tenorio, Jair
    Tong, Hoi
    Morales, Maria Teresa Garcia
    Avila, Jose Carlos Martinez
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [48] Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas
    Vakiani, E.
    Janackinaram, M.
    Shia, J.
    Saltz, L.
    Kemeny, N.
    Weiser, M.
    Solit, D.
    LABORATORY INVESTIGATION, 2011, 91 : 171A - 171A
  • [49] Analysis of gene mutations in KRAS, NRAS, BRAF, and PIK3CA in patients who received systemic chemotherapy with metastatic gastric cancer
    Fukahori, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [50] Started dose of regorafenib and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): A systematic review and meta-analysis
    Fedyanin, Mikhail
    Polyanskaya, Elizaveta
    Pokataev, Ilya
    Tryakin, Alexey
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345